Harbor Funds has filed regulatory paperwork for five Lab ETFs that would let everyday investors buy into private artificial intelligence companies. The funds, if approved, could open a corner of the market usually reserved for venture capital and institutional money.
But the filings also warn of concentrated risks and management fees that could eat into returns, raising questions about how well these products serve the average portfolio.
What's inside these Lab ETFs
The ETFs target private AI companies — startups and firms not listed on public exchanges. By bundling them into an ETF, Harbor Funds aims to provide a way for retail investors to get exposure to AI's growth without picking individual winners. The "Lab" label suggests a focus on early-stage or experimental AI firms.
The promise of democratization
The phrase "democratize AI investment" appears in the filings, according to sources. For years, investing in private AI required accreditation or large sums. These ETFs could lower the barrier, letting anyone with a brokerage account participate.
The risks investors face
The filings highlight potential concentrated risks. Because the ETFs focus on a narrow sector — private AI — a downturn in AI sentiment could hit hard. Additionally, management fees for actively managed or specialized ETFs tend to be higher than broad index funds, potentially eroding returns. Investors may find it hard to diversify within these funds.
The Securities and Exchange Commission will review the filings. No timeline is set. The question remains whether retail investors will embrace the concentrated bets or balk at the fees.
